Impact News +++ Earnings Call-Transkript: SCOR meldet starkes Gewinnwachstum für Q3 2025 (Investing.com DE) +++ SCOR Aktie -3,69%

MERIT MEDICAL Aktie

>MERIT MEDICAL Aktienkurs

75 EUR -0.7% (Tradegate)

Ask: 75.5 EUR / 300 Stück

Bid: 74 EUR / 300 Stück

Tagesumsatz: 170 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>MERIT MEDICAL Performance

1 Woche: +6,0%

1 Monat: +6,3%

3 Monate: +4,9%

6 Monate: -9,6%

1 Jahr: -14,2%

laufendes Jahr: -19,0%

>MERIT MEDICAL Aktie

Name:

MERIT MED. SYS

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US5898891040 / 882361

Symbol/ Ticker:

MM3 (Frankfurt) / MMSI (NASDAQ)

Kürzel:

FRA:MM3, ETR:MM3, MM3:GR, NASDAQ:MMSI

Index:

Webseite:

http://www.merit.com/

Profil:

Merit Medical Systems, Inc. is a renowned player w..
>Volltext..

Marktkapitalisierung:

4164.35 Mio. EUR

Unternehmenswert:

4569.99 Mio. EUR

Umsatz:

1235.51 Mio. EUR

EBITDA:

260.25 Mio. EUR

Nettogewinn:

102.92 Mio. EUR

Gewinn je Aktie:

1.75 EUR

Schulden:

708.96 Mio. EUR

Liquide Mittel:

297.11 Mio. EUR

Operativer Cashflow:

207.32 Mio. EUR

Bargeldquote:

1.52

Umsatzwachstum:

0.15%

Gewinnwachstum:

-7.76%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

MERIT MEDICAL

Letzte Datenerhebung:

31.10.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 59.22 Mio. St.

Frei handelbar: 97.54%

Leerverk. Aktien: 5.63%

Rückkaufquote: -1.04%

Mitarbeiter: 7400

Umsatz/Mitarb.: 0.16 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 22.99%

Bewertung:

KGV: 43.09

KGV lG: 22.99

KUV: 3.49

KBV: 3.38

PEG-Ratio: -

EV/EBITDA: 17.56

Rentabilität:

Bruttomarge: 47.95%

Gewinnmarge: 8.33%

Operative Marge: 12.18%

Managementeffizenz:

Gesamtkaprendite: 4.81%

Eigenkaprendite: 8.6%

>Peer Group

Es sind 596 Aktien bekannt.

>MERIT MEDICAL Chart & Kurs - NASDAQ

>MERIT MEDICAL News

31.10.25 - 03:21	Merit Medical targets $175M free cash flow in 2025 with updated guidance and new CEO at helm (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.25 - 02:15	Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

31.10.25 - 00:45	Merit Medical (MMSI) Q3 Earnings and Revenues Surpass Estimates (Zacks)
	Merit Medical (MMSI) delivered earnings and revenue surprises of +12.20% and +3.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

30.10.25 - 23:54	Merit Medical übertrifft Prognosen in Q3 2025 – Aktie legt zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.25 - 23:36	Merit Medical to acquire C2 CryoBalloon technology for $22M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.25 - 22:09	PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement (PR Newswire)
	Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J., Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit......

15.10.25 - 22:06

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology (GlobeNewswire EN)

SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX® Medical, Inc., to acquire the C2 CryoBalloon™ device and related technology. The closing of the proposed transaction is expected to occur during the fourth quarter of 2025, subject to the receipt or waiver (in accordance with the provisions of the asset purchase agreement) of certain customary closing conditions....

03.10.25 - 15:27

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 (GlobeNewswire EN)

SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific)....

01.10.25 - 15:27	Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology (GlobeNewswire EN)
	SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care...

30.09.25 - 17:30	Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term (Zacks)
	Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

15.09.25 - 20:30	MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care (Zacks)
	Merit Medical secures CE Mark for Embosphere, expanding its use in knee osteoarthritis treatment with a minimally invasive alternative....

12.09.25 - 20:33	Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis (GlobeNewswire EN)
	Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere's consistent, predictable, and effective clinical results. Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere's consistent, predictable, and effective clinical results....

25.08.25 - 23:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Merit Medical Systems im Wert von 265680 USD (Insiderkauf)
	Ward, Lynne N. - Aufsichtsrat - Tag der Transaktion: 2025-08-22...

18.08.25 - 15:27	First Patient Enrolled in Merit Medical′s WRAPSODY (WRAP) North America Registry (GlobeNewswire EN)
	SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enrollment of the first patient in the WRAP North America registry....

14.08.25 - 17:30	Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
	Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

12.08.25 - 20:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Merit Medical Systems im Wert von 206536 USD (Insiderkauf)
	Ward, Lynne - Aufsichtsrat - Tag der Transaktion: 2025-08-11...

07.08.25 - 15:27	Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology (GlobeNewswire EN)
	Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion...

01.08.25 - 12:12	Merit Medical (MMSI) Q2 Revenue Up 13% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

31.07.25 - 21:15	Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands (Zacks)
	MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth....

31.07.25 - 17:48	Merit Medical Systems outlines 2025 revenue guidance of 10–11% growth and updates WRAPSODY reimbursement timeline (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Lehrling hört mit Bangigkeit die sich kreuzenden Stimmen. Es scheint ihm jede Recht zu haben, und eine sonderbare Verwirrung bemächtigt sich seines Gemüts. - Novalis

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram